Vyome Holdings, Inc (HIND) stock
HINDNasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.51−0.03 (-2.27%)
Close on Nov 18, 2026Market cap $10.60MP/E –Yield –
Vyome net income
Net income is the profit left for shareholders after every expense, interest and tax.
Vyome's net income for the twelve months ending Jun 30, 2026 was -$11.31M. For fiscal 2025 it was -$10.26M. The highest annual figure on record is -$1.45M in fiscal 2024.
Annual net income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$10.26M | – |
| FY2024 | Dec 31, 2024 | -$1.45M | – |
| FY2023 | Dec 31, 2023 | -$11.39M | – |
| FY2022 | Dec 31, 2022 | -$46.21M | – |
| FY2021 | Dec 31, 2021 | -$63.15M | – |
| FY2020 | Dec 31, 2020 | -$21.63M | – |
| FY2019 | Dec 31, 2019 | -$23.68M | – |
| FY2018 | Dec 31, 2018 | -$37.38M | – |
| FY2017 | Dec 31, 2017 | -$34.77M | – |
| FY2016 | Dec 31, 2016 | -$20.47M | – |
| FY2015 | Dec 31, 2015 | -$15.56M | – |
| FY2014 | Dec 31, 2014 | -$9.89M | – |
Quarterly net income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$685.56K | – |
| Q1 FY2026 | Mar 31, 2026 | -$962.91K | – |
| Q4 FY2025 | Dec 31, 2025 | -$1.23M | – |
| Q3 FY2025 | Sep 30, 2025 | -$8.43M | – |
| Q2 FY2025 | Jun 30, 2025 | -$308.76K | – |
| Q1 FY2025 | Mar 31, 2025 | -$293.97K | – |
| Q4 FY2024 | Dec 31, 2024 | -$306.56K | – |
| Q3 FY2024 | Sep 30, 2024 | -$547.77K | – |
| Q2 FY2024 | Jun 30, 2024 | -$1.60M | – |
| Q1 FY2024 | Mar 31, 2024 | -$2.19M | – |
| Q4 FY2023 | Dec 31, 2023 | -$1.70M | – |
| Q3 FY2023 | Sep 30, 2023 | -$3.53M | – |
| Q2 FY2023 | Jun 30, 2023 | -$3.49M | – |
| Q1 FY2023 | Mar 31, 2023 | -$2.66M | – |
| Q4 FY2022 | Dec 31, 2022 | -$16.47M | – |
| Q3 FY2022 | Sep 30, 2022 | -$12.19M | – |
| Q2 FY2022 | Jun 30, 2022 | -$9.44M | – |
| Q1 FY2022 | Mar 31, 2022 | -$8.12M | – |
| Q4 FY2021 | Dec 31, 2021 | -$37.25M | – |
| Q3 FY2021 | Sep 30, 2021 | -$17.13M | – |
| Q2 FY2021 | Jun 30, 2021 | -$3.89M | – |
| Q1 FY2021 | Mar 31, 2021 | -$4.87M | – |
| Q4 FY2020 | Dec 31, 2020 | -$8.54M | – |
| Q3 FY2020 | Sep 30, 2020 | -$5.18M | – |
| Q2 FY2020 | Jun 30, 2020 | -$3.60M | – |
| Q1 FY2020 | Mar 31, 2020 | -$5.26M | – |
| Q4 FY2019 | Dec 31, 2019 | -$4.91M | – |
| Q3 FY2019 | Sep 30, 2019 | -$3.71M | – |
| Q2 FY2019 | Jun 30, 2019 | -$6.77M | – |
| Q1 FY2019 | Mar 31, 2019 | -$8.29M | – |
| Q4 FY2018 | Dec 31, 2018 | -$8.76M | – |
| Q3 FY2018 | Sep 30, 2018 | -$6.75M | – |
| Q2 FY2018 | Jun 30, 2018 | -$9.75M | – |
| Q1 FY2018 | Mar 31, 2018 | -$12.13M | – |
| Q4 FY2017 | Dec 31, 2017 | -$10.12M | – |
| Q3 FY2017 | Sep 30, 2017 | -$9.17M | – |
| Q2 FY2017 | Jun 30, 2017 | -$7.73M | – |
| Q1 FY2017 | Mar 31, 2017 | -$7.75M | – |
| Q4 FY2016 | Dec 31, 2016 | -$7.50M | – |
| Q3 FY2016 | Sep 30, 2016 | -$5.26M | – |
See a number that looks wrong?